WO1999000134A1 - New combination of antiasthma medicaments - Google Patents

New combination of antiasthma medicaments Download PDF

Info

Publication number
WO1999000134A1
WO1999000134A1 PCT/SE1998/001089 SE9801089W WO9900134A1 WO 1999000134 A1 WO1999000134 A1 WO 1999000134A1 SE 9801089 W SE9801089 W SE 9801089W WO 9900134 A1 WO9900134 A1 WO 9900134A1
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
rofleponide
composition
solvate
patient
Prior art date
Application number
PCT/SE1998/001089
Other languages
English (en)
French (fr)
Inventor
Bengt Axelsson
Leif Källström
Jan Trofast
Original Assignee
Astra Aktiebolag (Publ)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SK1847-99A priority Critical patent/SK184799A3/sk
Priority to JP50547999A priority patent/JP2002510310A/ja
Priority to EEP199900594A priority patent/EE9900594A/xx
Priority to BR9810452-7A priority patent/BR9810452A/pt
Priority to PL98337722A priority patent/PL337722A1/xx
Priority to CA002295076A priority patent/CA2295076A1/en
Application filed by Astra Aktiebolag (Publ) filed Critical Astra Aktiebolag (Publ)
Priority to IL13359798A priority patent/IL133597A0/xx
Priority to AU81350/98A priority patent/AU8135098A/en
Priority to EP98931163A priority patent/EP1009408A1/en
Publication of WO1999000134A1 publication Critical patent/WO1999000134A1/en
Priority to IS5303A priority patent/IS5303A/is
Priority to NO996438A priority patent/NO996438L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
PCT/SE1998/001089 1997-06-27 1998-06-08 New combination of antiasthma medicaments WO1999000134A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP50547999A JP2002510310A (ja) 1997-06-27 1998-06-08 抗喘息薬の新規配合
EEP199900594A EE9900594A (et) 1997-06-27 1998-06-08 Uued astmavastased ravimkoostised
BR9810452-7A BR9810452A (pt) 1997-06-27 1998-06-08 Nova combinação de medicamentos contra asma
PL98337722A PL337722A1 (en) 1997-06-27 1998-06-08 Novel combination antiasthmatic drugs
CA002295076A CA2295076A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments
SK1847-99A SK184799A3 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments
IL13359798A IL133597A0 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments
AU81350/98A AU8135098A (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments
EP98931163A EP1009408A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments
IS5303A IS5303A (is) 1997-06-27 1999-12-15 Ný blanda asmalyfja
NO996438A NO996438L (no) 1997-06-27 1999-12-23 Ny kombinasjon av antiastmamedikamenter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27
US08/883,823 1997-06-27

Publications (1)

Publication Number Publication Date
WO1999000134A1 true WO1999000134A1 (en) 1999-01-07

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1998/001089 WO1999000134A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Country Status (16)

Country Link
EP (1) EP1009408A1 (ja)
JP (1) JP2002510310A (ja)
KR (1) KR20010014162A (ja)
AU (1) AU8135098A (ja)
BR (1) BR9810452A (ja)
CA (1) CA2295076A1 (ja)
EE (1) EE9900594A (ja)
HU (1) HUP0002533A3 (ja)
ID (1) ID24063A (ja)
IL (1) IL133597A0 (ja)
IS (1) IS5303A (ja)
NO (1) NO996438L (ja)
PL (1) PL337722A1 (ja)
SK (1) SK184799A3 (ja)
TR (1) TR199903272T2 (ja)
WO (1) WO1999000134A1 (ja)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053187A1 (en) * 1999-03-09 2000-09-14 Astrazeneca Ab New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
WO2001078746A1 (en) * 2000-04-18 2001-10-25 Glaxo Group Limited Respiratory compositions
WO2001078738A1 (en) * 2000-04-18 2001-10-25 Glaxo Group Limited Medical compositions comprising (r,r)-formoterol and rofleponide
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
US6824761B1 (en) 1999-05-28 2004-11-30 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
US7348362B2 (en) 2003-07-10 2008-03-25 Dey, L.P. Bronchodilating β-agonist compositions and methods
US7897646B2 (en) 1997-09-19 2011-03-01 Astrazeneca Ab Use for budesonide and formoterol
US8623851B2 (en) 2001-04-17 2014-01-07 Mylan Specialty L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US9295644B2 (en) 1998-06-11 2016-03-29 Astrazeneca Ab Methods and compositions for treating asthma

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
WO1995005805A1 (en) * 1993-08-27 1995-03-02 Astra Aktiebolag Process for conditioning substances
WO1996019199A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Proliposome powders for inhalation
WO1996032095A1 (en) * 1995-04-13 1996-10-17 Astra Aktiebolag Process for the preparation of respirable particles
WO1998015280A1 (en) * 1996-10-08 1998-04-16 Astra Aktiebolag New combination

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
WO1995005805A1 (en) * 1993-08-27 1995-03-02 Astra Aktiebolag Process for conditioning substances
WO1996019199A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Proliposome powders for inhalation
WO1996032095A1 (en) * 1995-04-13 1996-10-17 Astra Aktiebolag Process for the preparation of respirable particles
WO1998015280A1 (en) * 1996-10-08 1998-04-16 Astra Aktiebolag New combination

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897646B2 (en) 1997-09-19 2011-03-01 Astrazeneca Ab Use for budesonide and formoterol
US8461211B2 (en) 1997-09-19 2013-06-11 Astrazeneca Ab Use for budesonide and formoterol
US9295644B2 (en) 1998-06-11 2016-03-29 Astrazeneca Ab Methods and compositions for treating asthma
US7273604B2 (en) 1998-11-26 2007-09-25 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
WO2000053187A1 (en) * 1999-03-09 2000-09-14 Astrazeneca Ab New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
US6824761B1 (en) 1999-05-28 2004-11-30 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
WO2001078746A1 (en) * 2000-04-18 2001-10-25 Glaxo Group Limited Respiratory compositions
WO2001078738A1 (en) * 2000-04-18 2001-10-25 Glaxo Group Limited Medical compositions comprising (r,r)-formoterol and rofleponide
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US9597396B2 (en) 2001-04-17 2017-03-21 Mylan Specialty Lp Formoterol/steroid bronchodilating compositions and methods of use thereof
US8623851B2 (en) 2001-04-17 2014-01-07 Mylan Specialty L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
US7541385B2 (en) 2003-07-10 2009-06-02 Chaudry Imtiaz A Bronchodilating β-agonist compositions and methods
US7473710B2 (en) 2003-07-10 2009-01-06 Jpmorgan Chase Bank, N.A. Bronchodilating beta-agonist compositions and methods
US7465756B2 (en) 2003-07-10 2008-12-16 Jpmorgan Chase Bank, N.A. Bronchodilating beta-agonist compositions and methods
US7462645B2 (en) 2003-07-10 2008-12-09 Jpmorgan Chase Bank, N.A. Bronchodilating beta-agonist compositions and methods
US7348362B2 (en) 2003-07-10 2008-03-25 Dey, L.P. Bronchodilating β-agonist compositions and methods
US9730890B2 (en) 2003-07-10 2017-08-15 Mylan Pharmaceuticals, Inc. Bronchodilating beta-agonist compositions and methods

Also Published As

Publication number Publication date
TR199903272T2 (xx) 2000-08-21
JP2002510310A (ja) 2002-04-02
BR9810452A (pt) 2000-09-05
IS5303A (is) 1999-12-15
AU8135098A (en) 1999-01-19
KR20010014162A (ko) 2001-02-26
NO996438L (no) 2000-02-28
EP1009408A1 (en) 2000-06-21
CA2295076A1 (en) 1999-01-07
SK184799A3 (en) 2000-06-12
ID24063A (id) 2000-07-06
HUP0002533A2 (hu) 2000-12-28
PL337722A1 (en) 2000-08-28
IL133597A0 (en) 2001-04-30
NO996438D0 (no) 1999-12-23
EE9900594A (et) 2000-08-15
HUP0002533A3 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
AU715319B2 (en) New combination
EP1085877B1 (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
AU673660C (en) New combination of formoterol and budesonide
US7897646B2 (en) Use for budesonide and formoterol
WO2000053187A1 (en) New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
EP1009408A1 (en) New combination of antiasthma medicaments
WO2000053188A1 (en) New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd
EP1101493A2 (en) New combination of formoterol and budesonide
MXPA99011676A (en) New combination of antiasthma medicaments
CZ466899A3 (cs) Nová kombinace antiastmatických léčiv
MXPA98004357A (en) New combination
MXPA00011806A (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 133597

Country of ref document: IL

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 81350/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1998931163

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 98805891.X

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 501673

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/011676

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: PV1999-4668

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2295076

Country of ref document: CA

Ref document number: 2295076

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 184799

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 1019997012233

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1999/03272

Country of ref document: TR

WWP Wipo information: published in national office

Ref document number: PV1999-4668

Country of ref document: CZ

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998931163

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997012233

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1999-4668

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1998931163

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019997012233

Country of ref document: KR